Moleculin Biotech faces critical funding test as Annamycin’s 43% leukemia remission rate advances toward pivotal readout
PulseAI wins FDA clearance for smartwatch ECG analysis after study shows 92% fewer inconclusive results
Read More General business news Joby Aviation to build defense business through $500m Resonant Sciences deal Joby Aviation will acquire Resonant Sciences for $500m in cash and stock, targeting a first-half 2027 close as it builds a dedicated defense business. byVenkateshAugust 11, 2026